| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/10/2013 | CN103191222A Application of hedan preparation in preparation of diabetes medicine |
| 07/10/2013 | CN103191221A Antiobesity effect of hedan preparation |
| 07/10/2013 | CN103191200A Medicinal composition for reducing blood fat and protecting liver and preparation method and application thereof |
| 07/10/2013 | CN103191176A Soybean phospholipids soft capsule and preparation method thereof |
| 07/10/2013 | CN103191174A Novel use of eucommia ulmoides chemical component as blood vessel protective agent |
| 07/10/2013 | CN103191171A Natural medicine for treating 2 type diabetes, and preparation method thereof |
| 07/10/2013 | CN103191170A Healthcare product for auxiliary treatment of type 2 diabetes, and preparation method thereof |
| 07/10/2013 | CN103191153A Muscular amino acid and nucleoside extract and pharmaceutical composition thereof |
| 07/10/2013 | CN103191134A Pharmaceutical composition of lipid-soluble vitamin and preparation method thereof |
| 07/10/2013 | CN103191119A Use of itraconazole in inhibiting of Akt kinase (protein kinase B) activity |
| 07/10/2013 | CN103191118A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 07/10/2013 | CN103191115A Application of pyrroloquinoline quinone (PQQ) in treatment and/or improvement of diabetic foot |
| 07/10/2013 | CN103191092A Pharmaceutical composition with effects of supplying calcium and zinc |
| 07/10/2013 | CN103191081A Vitamin E soft capsules and preparation method thereof |
| 07/10/2013 | CN103191077A Gliclazide tablet and preparation method thereof |
| 07/10/2013 | CN103191072A Simvastatin tablets and preparation method thereof |
| 07/10/2013 | CN103191053A Calcium borogluconate solution and preparation method thereof |
| 07/10/2013 | CN103191045A Facial beautifying fire-clearing collagen paste, and preparation method and uses thereof |
| 07/10/2013 | CN103190618A Gynostemma pentaphyllum-propolis composite soft capsule and preparation method thereof |
| 07/10/2013 | CN103190611A Chrysanthemum capsules with blood sugar reducing function and preparation method thereof |
| 07/10/2013 | CN102727728B Resurgent traditional Chinese herbal preparation |
| 07/10/2013 | CN102698280B Tagatose tablet excipient, medicinal tablet and preparation method of medicinal tablet |
| 07/10/2013 | CN102698247B Glutamine dipeptide and compound amino acid medicinal composition prepared with solvent crystallization method |
| 07/10/2013 | CN102630817B Rumen-protected chlorine chloride microcapsule additive and preparation method thereof |
| 07/10/2013 | CN102579915B Medicine for treating wound non-healing of diabetics |
| 07/10/2013 | CN102373210B MicroRNA (Ribonucleic Acid) relevant to diabetes mellitus endothelial progenitor cell paralysis and application thereof |
| 07/10/2013 | CN102370763B Application of Chinese medicinal herb immature bitter orange extract in preparation of weight-reducing and lipid-lowering medicament or preparation of medicament having lipase activity suppressing effect |
| 07/10/2013 | CN102370694B Application of Chinese herbal medicine shrubby sophora extract in preparation of weight losing and lipid lowering medicament or medicament with lipase activity suppression effect |
| 07/10/2013 | CN102370689B Application of extracts of Chinese herbal medicine folium sennae in preparation of weight-losing and lipid-lowering medicines or medicines with function of inhibiting lipase activity |
| 07/10/2013 | CN102366595B Medicine for treating diabetes and preparation method thereof |
| 07/10/2013 | CN102366433B Application of Chinese medicinal chrysanthemum extract in preparing medicaments with lipase activity-inhibiting action |
| 07/10/2013 | CN102357226B Application of Chinese herbal medicine turmeric extraction in preparation of drug with lipase activity inhibition effect |
| 07/10/2013 | CN102357150B Application of extractive of Chinese herbal medicine medlar to prepare medicines with effects of inhibiting lipase activity |
| 07/10/2013 | CN102357120B Application of extractive of Chinese herbal medicine scutellaria baicalensis to prepare medicines with effects of inhibiting lipase activity |
| 07/10/2013 | CN102357114B Application of Chinese herbal medicine kudzu root extracts in preparation of medicines with lipase activity inhibition effect |
| 07/10/2013 | CN102357113B Application of Chinese herbal medicine fiveleaf gynostemma in preparation of drug with lipase activity inhibition effect |
| 07/10/2013 | CN102357106B Application of Chinese herbal medicine campsis grandiflora extracts in preparation of weight-losing lipid-lowering medicines or medicines with lipase activity inhibition effect |
| 07/10/2013 | CN102293868B Application of total flavonoids of lilac daphne root in preparation of medicament for reducing blood sugar |
| 07/10/2013 | CN102283834B Orlisat-containing medicinal composition and application thereof |
| 07/10/2013 | CN102240302B Chinese medicine composition of super gene active peptide |
| 07/10/2013 | CN102145174B Chondroitin sulfate nano-selenium and preparation method thereof |
| 07/10/2013 | CN101903352B Substituted 3-hydroxypyridines and pharmaceutical compositions thereof |
| 07/10/2013 | CN101822660B Application of rhein compound or its salt in preparing drugs preventing and curing hypofunction of islet beta cell |
| 07/10/2013 | CN101773605B Herbal wasting-thirst penetrant for treating diabetes |
| 07/10/2013 | CN101768080B Medicinal compound and medicinal use thereof |
| 07/10/2013 | CN101591324B Three crystal forms of 5-methyl-7-methoxy-isoflavone, preparation method thereof, medicine composition thereof and application |
| 07/10/2013 | CN101591323B Five crystal forms of 7-hydroxy-isoflavone, preparation method thereof, medicine composition thereof and application |
| 07/10/2013 | CN101516450B Use of quinoa extract as cosmetic and pharmaceutical slimming agent and/or as an agent preventing the formation of new fats in the human body |
| 07/10/2013 | CN101410362B Lipid derivatives |
| 07/10/2013 | CN101130526B Aryl carbonyl derivatives as therapeutic agents |
| 07/09/2013 | US8481731 Compounds, pharmaceutical composition and methods relating thereto |
| 07/09/2013 | US8481562 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
| 07/09/2013 | US8481490 Method of reducing plasma amylase and/or plasma lipase in patients with pancreatitis |
| 07/09/2013 | US8481489 GH secretagogues and uses thereof |
| 07/09/2013 | US8481485 Insulin analogs |
| 07/09/2013 | US8481484 Cyclic heptapeptide and use of the same |
| 07/09/2013 | US8481076 Bariatric magnetic apparatus and method of manufacturing thereof |
| 07/09/2013 | US8480995 Use of sodium selenosulfate for supplementing selenium and enhancing the therapeutic efficacy of chemotherapy agents, and a rapid process for preparing sodium selenosulfate |
| 07/09/2013 | CA2722087C 4-dimethylaminobutyric acid derivatives |
| 07/09/2013 | CA2682736C Combined use of dipeptidyl peptidase 4 inhibitor and sweetener |
| 07/09/2013 | CA2671749C Bicyclic compounds and uses as antidiabetics |
| 07/09/2013 | CA2648936C Glp-1 compounds |
| 07/09/2013 | CA2640414C Combinations of botanical extracts for promoting cardiovascular health |
| 07/09/2013 | CA2577408C Use of (halobenzyloxy) benzylamino-propanamides for the manufacture of medicaments active as sodium and/or calcium channel selective modulators |
| 07/09/2013 | CA2567298C Methods and related compositions for reduction of fat |
| 07/09/2013 | CA2566343C Nutritional composition for increasing creatine uptake in skeletal muscle |
| 07/09/2013 | CA2527039C Grf analog compositions and their use |
| 07/09/2013 | CA2516407C Heteroarylcarbamoylbenzene derivatives |
| 07/09/2013 | CA2408408C Modulators of tnf- alpha signaling |
| 07/04/2013 | WO2013102207A1 Estrogen receptor modulators for reducing body weight |
| 07/04/2013 | WO2013102195A1 Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives |
| 07/04/2013 | WO2013101954A1 3-phenyl-5-ureidoisothiazole-4-carboximide and 3-amino-5-phenylisothiazole derivatives as kinase inhibitors |
| 07/04/2013 | WO2013098775A1 Improved process for preparation of pure linagliptin |
| 07/04/2013 | WO2013098764A1 Fgf receptor (fgfr) agonist dimeric compounds, process for the preparation thereof and therapeutic use thereof |
| 07/04/2013 | WO2013098408A1 Glucagon and cck receptor agonist peptide conjugates |
| 07/04/2013 | WO2013098373A1 New azetidine derivatives, pharmaceutical compositions and uses thereof |
| 07/04/2013 | WO2013098372A1 Subcutaneous therapeutic use of dpp-4 inhibitor |
| 07/04/2013 | WO2013097773A1 Novel arylalkene derivatives and use thereof as selective estrogen receptor modulators |
| 07/04/2013 | WO2013097601A1 Bromodomain inhibitors |
| 07/04/2013 | WO2013097052A1 Bromodomain inhibitors |
| 07/04/2013 | WO2013058627A3 Composition including rebamipide as an active ingredient for preventing or treating obesity |
| 07/04/2013 | WO2013055385A3 Methods of treating age related disorders |
| 07/04/2013 | WO2013054364A3 Novel salts of sitagliptin, process for the preparation and pharmaceutical composition thereof |
| 07/04/2013 | US20130172970 Heat Patch For Obesity |
| 07/04/2013 | US20130172349 Inhibitors of phosphatidylinositol 3-kinase |
| 07/04/2013 | US20130172251 Modified ghrelin peptides |
| 07/04/2013 | US20130171200 Heat Patch for Diabetes |
| 07/04/2013 | CA2858285A1 1,3-diphenylpropane derivatives, preparations and uses thereof |
| 07/03/2013 | EP2609095A2 Compounds that modulate intracellular calcium |
| 07/03/2013 | EP2608812A2 Methods targeting mir-33 micrornas for regulating lipid metabolism |
| 07/03/2013 | EP2608794A1 Methods and compositions for preventing or treating obesity |
| 07/03/2013 | EP2608788A1 Polymorphs of saxagliptin hydrochloride and processes for preparing them |
| 07/03/2013 | EP2608787A1 Proline sulfonamide derivatives as orexin receptor antagonists |
| 07/03/2013 | EP2608670A1 Methods for treating antipsychotic-induced weight gain |
| 07/03/2013 | CN1919229B Bauhinia hupehara C. and its extract for the treatment of diabetes and obesity |
| 07/03/2013 | CN103189375A Hydrate of 1-{(2s)-2-amino-4-[2,4-bis(trifluoromethyl)-5,8-di- hydropyrido[3,4-d]pyrimidin-7(6h)-yl]-4-oxobutyl}-5,5-difluoro-piperidin-2-one tartrate |
| 07/03/2013 | CN103189360A Non-hygroscopic salts of 5-HT2C agonists |
| 07/03/2013 | CN103189359A Salts of lorcaserin with optically active acids |
| 07/03/2013 | CN103189358A Fast-dissolve dosage forms of 5-ht2c agonists |
| 07/03/2013 | CN103184170A Novel Lactobacillus LY-73 and its application |